What Instil Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO | Sep 10 | Open-market sale · S | −12,461 | $23.88 | −$298K | 0 |
| Laumas Sandeep | CFO and CBO | Sep 10 | Open-market sale · S | −17,539 | $23.04 | −$404K | 12,461 |
| Laumas Sandeep | CFO and CBO | Sep 10 | Exercise / conversion · M | +13,000 | $12.68 | +$165K | 30,000 |
| Laumas Sandeep | CFO and CBO | Sep 10 | Exercise / conversion · M | +17,000 | $11.60 | +$197K | 17,000 |
| McGaughy R Kent Jr | Director | Mar 15 | Other Transaction · J | −260,323 | — | — | 8,218,467 |
| Shah Nimish P | Director | Mar 23 | Open-market buy · P | +19,620 | $20.00 | +$392K | 19,620 |
| Shah Nimish P | Director | Mar 23 | Open-market buy · P | +48,390 | $20.00 | +$968K | 48,390 |
| Shah Nimish P | Director | Mar 23 | Open-market buy · P | +116,880 | $20.00 | +$2.34M | 597,596 |
| Shah Nimish P | Director | Mar 23 | Open-market buy · P | +10,470 | $20.00 | +$209K | 563,533 |
| Shah Nimish P | Director | Mar 23 | Open-market buy · P | +104,640 | $20.00 | +$2.09M | 5,635,937 |
| Shah Nimish P | Director | Mar 23 | Derivative Conversion · C | +480,716 | — | — | 480,716 |
| Shah Nimish P | Director | Mar 23 | Derivative Conversion · C | +43,033 | — | — | 553,063 |
| Shah Nimish P | Director | Mar 23 | Derivative Conversion · C | +430,431 | — | — | 5,531,297 |
| Shah Nimish P | Director | Mar 23 | Derivative Conversion · C | +510,030 | — | — | 510,030 |
| Shah Nimish P | Director | Mar 23 | Derivative Conversion · C | +5,100,866 | — | — | 5,100,866 |
| Nielsen Jack | Director | Mar 23 | Open-market buy · P | +300,000 | $20.00 | +$6M | 12,486,787 |
| Nielsen Jack | Director | Mar 23 | Derivative Conversion · C | +477,091 | — | — | 12,186,787 |
| Nielsen Jack | Director | Mar 23 | Derivative Conversion · C | +11,709,696 | — | — | 11,709,696 |
| McGaughy R Kent Jr | Director | Mar 23 | Open-market buy · P | +450,000 | $20.00 | +$9M | 8,478,790 |
| McGaughy R Kent Jr | Director | Mar 23 | Derivative Conversion · C | +954,182 | — | — | 8,028,790 |
Loading...